サワイグループホールディングスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/07/22 | 6,780 | 6,863 | 6,698 | 6,700 | -39 | -0.6% | 183,500 |
| 2024/07/19 | 6,690 | 6,764 | 6,629 | 6,739 | +71 | +1.1% | 194,700 |
| 2024/07/18 | 6,725 | 6,750 | 6,666 | 6,668 | -71 | -1.1% | 108,700 |
| 2024/07/17 | 6,681 | 6,772 | 6,662 | 6,739 | +99 | +1.5% | 204,100 |
| 2024/07/16 | 6,710 | 6,715 | 6,610 | 6,640 | -85 | -1.3% | 147,500 |
| 2024/07/12 | 6,671 | 6,748 | 6,665 | 6,725 | +26 | +0.4% | 135,300 |
| 2024/07/11 | 6,750 | 6,804 | 6,661 | 6,699 | -10 | -0.1% | 232,800 |
| 2024/07/10 | 6,610 | 6,731 | 6,596 | 6,709 | +99 | +1.5% | 216,000 |
| 2024/07/09 | 6,589 | 6,613 | 6,478 | 6,610 | +65 | +1% | 185,600 |
| 2024/07/08 | 6,550 | 6,662 | 6,530 | 6,545 | ±0 | ±0% | 219,500 |
| 2024/07/05 | 6,657 | 6,689 | 6,519 | 6,545 | -112 | -1.7% | 199,400 |
| 2024/07/04 | 6,495 | 6,660 | 6,495 | 6,657 | +162 | +2.5% | 251,500 |
| 2024/07/03 | 6,550 | 6,571 | 6,457 | 6,495 | -105 | -1.6% | 363,600 |
| 2024/07/02 | 6,680 | 6,745 | 6,505 | 6,600 | -72 | -1.1% | 358,500 |
| 2024/07/01 | 6,565 | 6,697 | 6,559 | 6,672 | +135 | +2.1% | 313,700 |
| 2024/06/28 | 6,451 | 6,538 | 6,416 | 6,537 | +158 | +2.5% | 285,400 |
| 2024/06/27 | 6,400 | 6,487 | 6,325 | 6,379 | +15 | +0.2% | 356,700 |
| 2024/06/26 | 6,336 | 6,434 | 6,256 | 6,364 | +499 | +8.5% | 835,100 |
| 2024/06/25 | 5,830 | 5,901 | 5,812 | 5,865 | +20 | +0.3% | 126,700 |
| 2024/06/24 | 5,865 | 5,880 | 5,820 | 5,845 | +115 | +2% | 177,700 |
| 2024/06/21 | 5,708 | 5,780 | 5,692 | 5,730 | +68 | +1.2% | 243,600 |
| 2024/06/20 | 5,629 | 5,770 | 5,610 | 5,662 | -5 | -0.1% | 179,600 |
| 2024/06/19 | 5,580 | 5,719 | 5,579 | 5,667 | +114 | +2.1% | 191,800 |
| 2024/06/18 | 5,667 | 5,717 | 5,548 | 5,553 | -97 | -1.7% | 122,900 |
| 2024/06/17 | 5,730 | 5,780 | 5,627 | 5,650 | -73 | -1.3% | 131,400 |
| 2024/06/14 | 5,675 | 5,766 | 5,652 | 5,723 | -52 | -0.9% | 171,300 |
| 2024/06/13 | 5,830 | 5,866 | 5,762 | 5,775 | -40 | -0.7% | 128,300 |
| 2024/06/12 | 5,771 | 5,845 | 5,770 | 5,815 | +25 | +0.4% | 156,800 |
| 2024/06/11 | 5,750 | 5,880 | 5,750 | 5,790 | -18 | -0.3% | 144,300 |
| 2024/06/10 | 5,709 | 5,842 | 5,703 | 5,808 | +121 | +2.1% | 228,600 |
| 2024/06/07 | 6,047 | 6,065 | 5,668 | 5,687 | -260 | -4.4% | 625,900 |
| 2024/06/06 | 5,903 | 5,988 | 5,903 | 5,947 | -11 | -0.2% | 277,100 |
| 2024/06/05 | 5,980 | 6,015 | 5,840 | 5,958 | -101 | -1.7% | 316,600 |
| 2024/06/04 | 6,196 | 6,218 | 6,030 | 6,059 | -54 | -0.9% | 266,800 |
| 2024/06/03 | 6,212 | 6,287 | 6,110 | 6,113 | +1 | ±0% | 176,400 |
| 2024/05/31 | 5,974 | 6,150 | 5,963 | 6,112 | +338 | +5.9% | 502,100 |
| 2024/05/30 | 5,750 | 5,845 | 5,730 | 5,774 | -16 | -0.3% | 177,100 |
| 2024/05/29 | 5,799 | 5,805 | 5,715 | 5,790 | -9 | -0.2% | 128,800 |
| 2024/05/28 | 5,850 | 5,888 | 5,790 | 5,799 | -27 | -0.5% | 126,400 |
| 2024/05/27 | 5,841 | 5,870 | 5,790 | 5,826 | -4 | -0.1% | 119,600 |
| 2024/05/24 | 5,890 | 5,953 | 5,810 | 5,830 | -94 | -1.6% | 173,100 |
| 2024/05/23 | 5,910 | 5,981 | 5,832 | 5,924 | +9 | +0.2% | 142,100 |
| 2024/05/22 | 6,081 | 6,096 | 5,871 | 5,915 | -200 | -3.3% | 211,700 |
| 2024/05/21 | 6,093 | 6,230 | 6,080 | 6,115 | +10 | +0.2% | 165,500 |
| 2024/05/20 | 6,125 | 6,188 | 6,079 | 6,105 | -39 | -0.6% | 129,400 |
| 2024/05/17 | 5,965 | 6,181 | 5,927 | 6,144 | +152 | +2.5% | 168,600 |
| 2024/05/16 | 6,239 | 6,273 | 5,992 | 5,992 | -291 | -4.6% | 254,900 |
| 2024/05/15 | 6,435 | 6,435 | 6,238 | 6,283 | -78 | -1.2% | 383,800 |
| 2024/05/14 | 6,435 | 6,645 | 6,214 | 6,361 | +716 | +12.7% | 1,511,300 |
| 2024/05/13 | 5,797 | 5,799 | 5,614 | 5,645 | -155 | -2.7% | 224,300 |
201～
250
件表示中 / 1010件
類似銘柄と比較する
現在ご覧いただいている「サワイＧＨＤ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| サワイＧＨＤ | 177,100円 | +5.9% | +24.5% | 3.11% | 11.75倍 | 1.11倍 |
|
ジェネリック（後発）薬大手メーカー。２１年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
| 日本新薬 | 343,200円 | +8.0% | -15.3% | 3.61% | 9.64倍 | 0.94倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| ペプチド | 172,800円 | +5.0% | +1.5% | 0.00% | 14.78倍 | 3.94倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| キッセイ薬 | 387,000円 | +3.6% | +6.1% | 3.10% | 13.04倍 | 0.77倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| 鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.46倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
市場注目の銘柄
チャート関連のコラム
